Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Remdesivir for the Treatment of Covid-19 -- Final Report.

Subjects: NATIONAL Institute of Allergy & Infectious Diseases (U.S.); COVID-19 treatment; REMDESIVIR

  • Source: New England Journal of Medicine. 11/5/2020, Vol. 383 Issue 19, p1813-1826. 14p.

  • Abstract: BACKGROUND Although several therapeutic agents have been evaluated for the treatment of coronavirus disease 2019 (Covid-19), no antiviral ... Copyright of New England Journal of Medicine is the property of New England Journal of Medicine ...

Record details

×
Academic Journal

The Untold Toll — The Pandemic’s Effects on Patients without Covid-19.

Subjects: COVID-19; PANDEMICS; COVID-19 pandemic

  • Source: New England Journal of Medicine. 6/11/2020, Vol. 382 Issue 24, p2368-2371. 4p.

  • Abstract: The article offers information about the Covid-19 pandemic's effects on patients without Covid-19. It discusses the

Record details

×
Academic Journal

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.

Subjects: HYDROXYCHLOROQUINE; COVID-19; HOSPITAL patients

  • Source: New England Journal of Medicine. 7/18/2020, Vol. 382 Issue 25, p2411-2418. 8p.

  • Abstract: BACKGROUND Hydroxychloroquine has been widely administered to patients with Covid-19 without robust evidence supporting its use. METHODS We examined the association ... Copyright of New England Journal of Medicine is the property of New England Journal of Medicine ...

Record details

×
Academic Journal

Compassionate Use of Remdesivir for Patients with Severe Covid-19.

Subjects: COVID-19; REMDESIVIR; RNA polymerases

  • Source: New England Journal of Medicine. 6/11/2020, Vol. 382 Issue 24, p2327-2336. 10p.

  • Abstract: BACKGROUND Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases, has shown in vitro activity against SARS-CoV-2. METHODS We provided ... Copyright of New England Journal of Medicine is the property of New England Journal of Medicine ...

Record details

×
Academic Journal

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.

Subjects: GILEAD Sciences Inc.; COVID-19; REMDESIVIR

  • Source: New England Journal of Medicine. 11/5/2020, Vol. 383 Issue 19, p1827-1837. 11p.

  • Abstract: Background: Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro and efficacy in animal models of coronavirusCopyright of New England Journal of Medicine is the property of New England Journal of Medicine ...

Record details

×
Academic Journal

History in a Crisis — Lessons for Covid-19.

Subjects: COVID-19; MEDICAL personnel; EMERGING infectious diseases

  • Source: New England Journal of Medicine. 4/30/2020, Vol. 382 Issue 18, p1681-1683. 3p.

  • Abstract: In this article the author talks about crisis in previous centuries and offered several lesson for Covid-19. topics discussed herpes and ...

Record details

×
Academic Journal

Neuropathological Features of Covid-19.

Subjects: COVID-19; COMMUNITY-acquired pneumonia; MEDICAL societies

  • Source: New England Journal of Medicine. 9/3/2020, Vol. 383 Issue 10, p989-992. 4p.

  • Abstract: The article offers information about the neuropathological features of Covid-19 pandemic in the U.S. It mentions the neuropathological findings from ...

Record details

×
Academic Journal

Defining the Epidemiology of Covid-19 - Studies Needed.

Subjects: PREVENTION of epidemics; PREVENTION of infectious disease transmission; AGE distributionCHINA

  • Source: New England Journal of Medicine. 3/26/2020, Vol. 382 Issue 13, p1194-1196. 3p.

  • Abstract: The article offers information on the epidemiology of Covid-19. Topics discussed include the impact of an epidemic depends on the number ...

Record details

×
Academic Journal

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.

Subjects: COVID-19; HYDROXYCHLOROQUINE; MEDICAL masksCANADA

  • Source: New England Journal of Medicine. 8/6/2020, Vol. 383 Issue 6, p517-525. 9p.

  • Abstract: Background: Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory syndrome ... Copyright of New England Journal of Medicine is the property of New England Journal of Medicine ...

Record details

×
Academic Journal

Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.

Subjects: RENIN-angiotensin system; ALDOSTERONE antagonists; COVID-19

  • Source: New England Journal of Medicine. 7/18/2020, Vol. 382 Issue 25, p2441-2448. 8p.

  • Abstract: Background: There is concern about the potential of an increased risk related to medications that act on the renin-angiotensin-aldosterone system in patients exposed ... Copyright of New England Journal of Medicine is the property of New England Journal of Medicine ...

Record details

×
  • 1-10 of  454 results for "COVID-19"